T. Psillakis et al., Carbamazepine levels in head hair of patients under long-term treatment: Amethod to evaluate the history of drug use, J CLIN PHAR, 39(1), 1999, pp. 55-67
Carbamazepine (CBZ) concentrations were determined in the sections of head
hair from 40 patients (22 males and 18 females), ages 5 to 81, who were rec
eiving this drug systemically. Hair treatment included dissolution, liquid
phase extraction procedures, and immunoassay (Abbott TDx) or high-pressure
liquid chromatography (HPLC) analytical techniques. The mean values of CBZ
levels in the hair from the 1st section (close to hair root) to the 5th sec
tion for female patients were 26.82, 19.18, 17.28, 15.09, and 14.62 mu g/g
according to HPLC measurements. Immunoassay gave generally slightly higher
results. The mean values of CBZ in the hair sections according to the immun
oassay technique were 30.53, 21.90, 19.83, 1745 and 26.99 mu g/g, respectiv
ely, from the 1st to the 5th sections. The corresponding mean values for ma
le patients by HPLC and immunoassay techniques were 21.97 1730, 15.03, 13.0
2, and 12.21 mu g/g and 25.98, 20.52, 17.15, 14.87 and 12.31 mu g/g. Genera
lly, a reduction of drug concentrations in hair from the first to the subse
quent segments was observed. Higher amounts of CBZ were deposited in black,
untreated hair (e.g, not dyed or permed). CBZ concentrations in hair secti
ons were found to be dependent on the dosage (r = 0.979, p less than or equ
al to 0.002) but not on the gender. The data indicate the possible use of h
air section testing as a marker of the dosage history and the compliance of
patients under long-term treatment with CBZ. Journal of Clinical Pharmacol
ogy, 1999;39:55-67 (C) 1999 the American College of Clinical Pharmacology.